Recalls & Warnings December 12, 2022 FDA Warns Saffron USA for Promoting Teas to Treat Insomnia, Osteoporosis & Cancer On September 23, 2022, the FDA issued a warning letter to Saffron USA LLC following inspection of the companys website which found statements about its Allergy Blend, Chamomile Tea Petals, Diabetic Support Blend, Orange Blast Tea, and Saffron Loose Tea products to be drug
doi: 10.1172/JCI134778 36 TonelliCChioIICTuvesonDA
What is the Prognosis for Cat IBD
Lipovac M, Bodner F, Imhof M, Chedraui P
If your nutrition, sleep, and movement patterns dont support collagen production and tissue remodeling, even the best peptide wont deliver full results
Wonder why warfarin, ibuprofen, THC, or other drugs hit you harder than others